ID

37203

Beskrivning

Zibotentan Better Renal Scleroderma Outcome Study; ODM derived from: https://clinicaltrials.gov/show/NCT02047708

Länk

https://clinicaltrials.gov/show/NCT02047708

Nyckelord

Versioner (1)
  1. 2019-07-07 2019-07-07 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

7 juli 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Scleroderma NCT02047708

Engelsk

Eligibility Scleroderma NCT02047708

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. adults with scleroderma and:
Beskrivning

Adult | Scleroderma

Datatyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0011644
2. ckd 2/3 (zebra 1)
Beskrivning

Chronic Kidney Diseases

Datatyp

boolean

Alias
UMLS CUI [1]
C1561643
3. renal crisis not on dialysis (zebra 2a)
Beskrivning

Kidney crisis | Dialysis Absent

Datatyp

boolean

Alias
UMLS CUI [1]
C1408261
UMLS CUI [2,1]
C0011946
UMLS CUI [2,2]
C0332197
4. renal crisis on dialysis (zebra 2b)
Beskrivning

Kidney crisis | Dialysis

Datatyp

boolean

Alias
UMLS CUI [1]
C1408261
UMLS CUI [2]
C0011946
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. previous use of an endothelin receptor antagonist within 3 months of the study start
Beskrivning

Endothelin receptor antagonist

Datatyp

boolean

Alias
UMLS CUI [1]
C1134681
2. significant abnormalities in liver function testing (alt, alp, bilirubin) more than three times upper limit of normal)
Beskrivning

Liver Function Tests Abnormality | Alanine aminotransferase increased | Aspartate aminotransferase increased | Elevated total bilirubin

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0023901
UMLS CUI [1,2]
C1704258
UMLS CUI [2]
C0151905
UMLS CUI [3]
C0151904
UMLS CUI [4]
C0741494
3. patients with body weight <40kg.
Beskrivning

Body Weight

Datatyp

boolean

Alias
UMLS CUI [1]
C0005910
4. patients with conditions which prevent compliance with the protocol or failure to adhere to therapy.
Beskrivning

Patient condition Preventing Protocol Compliance | Patient condition Treatment Compliance failed

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0683521
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C0683521
UMLS CUI [2,2]
C4319828
UMLS CUI [2,3]
C0231175
5. patients with any other life threatening condition.
Beskrivning

Condition Life Threatening

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2826244
6. patients with known hypersensitivity to zibotentan or its excipients
Beskrivning

Hypersensitivity Zibotentan | Hypersensitivity Zibotentan Excipient

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2713006
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2713006
UMLS CUI [2,3]
C0015237
7. previous history of epilepsy or other cns aes, neurologic symptoms or signs consistent with acute or evolving spinal cord compression, and cns metastases
Beskrivning

Epilepsy | Central Nervous System Adverse events | Neurologic Symptoms Consistent with Compression of spinal cord | Neurologic Signs Consistent with Compression of spinal cord | CNS metastases

Datatyp

boolean

Alias
UMLS CUI [1]
C0014544
UMLS CUI [2,1]
C3714787
UMLS CUI [2,2]
C0877248
UMLS CUI [3,1]
C0235031
UMLS CUI [3,2]
C0332290
UMLS CUI [3,3]
C0037926
UMLS CUI [4,1]
C0751378
UMLS CUI [4,2]
C0332290
UMLS CUI [4,3]
C0037926
UMLS CUI [5]
C0686377
8. patients with a baseline left ventricular ejection fraction < 40% (prior to any scleroderma renal crisis), patients with acute myocardial infarction within six months or patients who are judged by the trial clinician to be at unacceptable risk from cardiac complications.
Beskrivning

Left ventricular ejection fraction | Status pre- Scleroderma renal crisis | Myocardial Infarction | Patients At risk Cardiac complication

Datatyp

boolean

Alias
UMLS CUI [1]
C0428772
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C1262147
UMLS CUI [3]
C0027051
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C1444641
UMLS CUI [4,3]
C0161816
9. history of chronic alcohol or drug abuse or any condition associated with poor compliance as judged by the investigator
Beskrivning

Substance Use Disorders chronic | Condition Associated with Poor compliance

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0332281
UMLS CUI [2,3]
C0032646
10. patients receiving cyclosporin a within 1 week of screening or expecting to receive this agent during the study.
Beskrivning

Cyclosporine A | Cyclosporine A Expected

Datatyp

boolean

Alias
UMLS CUI [1]
C0010592
UMLS CUI [2,1]
C0010592
UMLS CUI [2,2]
C1517001
11. patients who have received an investigational agent in the month prior to screening. these patients may be eligible if after a month of washout period, they are still within 112 months of the onset of the scleroderma renal crisis.
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
12. active malignancy or neoplastic disease in the previous 12 months
Beskrivning

Malignant Neoplasms | Neoplastic disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C1882062
13. women who rely on oestrogencontaining contraceptives (due to potential drug interaction with zibotentan).
Beskrivning

Gender | Estrogen Contraceptive Agents

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0009907
14. females who are pregnant or breastfeeding.
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Tillbaka till toppen

Similar models

Eligibility Scleroderma NCT02047708

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Scleroderma
Item
1. adults with scleroderma and:
boolean
C0001675 (UMLS CUI [1])
C0011644 (UMLS CUI [2])
Chronic Kidney Diseases
Item
2. ckd 2/3 (zebra 1)
boolean
C1561643 (UMLS CUI [1])
Kidney crisis | Dialysis Absent
Item
3. renal crisis not on dialysis (zebra 2a)
boolean
C1408261 (UMLS CUI [1])
C0011946 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Kidney crisis | Dialysis
Item
4. renal crisis on dialysis (zebra 2b)
boolean
C1408261 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Endothelin receptor antagonist
Item
1. previous use of an endothelin receptor antagonist within 3 months of the study start
boolean
C1134681 (UMLS CUI [1])
Liver Function Tests Abnormality | Alanine aminotransferase increased | Aspartate aminotransferase increased | Elevated total bilirubin
Item
2. significant abnormalities in liver function testing (alt, alp, bilirubin) more than three times upper limit of normal)
boolean
C0023901 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0741494 (UMLS CUI [4])
Body Weight
Item
3. patients with body weight <40kg.
boolean
C0005910 (UMLS CUI [1])
Patient condition Preventing Protocol Compliance | Patient condition Treatment Compliance failed
Item
4. patients with conditions which prevent compliance with the protocol or failure to adhere to therapy.
boolean
C0683521 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0683521 (UMLS CUI [2,1])
C4319828 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
Condition Life Threatening
Item
5. patients with any other life threatening condition.
boolean
C0348080 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
Hypersensitivity Zibotentan | Hypersensitivity Zibotentan Excipient
Item
6. patients with known hypersensitivity to zibotentan or its excipients
boolean
C0020517 (UMLS CUI [1,1])
C2713006 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2713006 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
Epilepsy | Central Nervous System Adverse events | Neurologic Symptoms Consistent with Compression of spinal cord | Neurologic Signs Consistent with Compression of spinal cord | CNS metastases
Item
7. previous history of epilepsy or other cns aes, neurologic symptoms or signs consistent with acute or evolving spinal cord compression, and cns metastases
boolean
C0014544 (UMLS CUI [1])
C3714787 (UMLS CUI [2,1])
C0877248 (UMLS CUI [2,2])
C0235031 (UMLS CUI [3,1])
C0332290 (UMLS CUI [3,2])
C0037926 (UMLS CUI [3,3])
C0751378 (UMLS CUI [4,1])
C0332290 (UMLS CUI [4,2])
C0037926 (UMLS CUI [4,3])
C0686377 (UMLS CUI [5])
Left ventricular ejection fraction | Status pre- Scleroderma renal crisis | Myocardial Infarction | Patients At risk Cardiac complication
Item
8. patients with a baseline left ventricular ejection fraction < 40% (prior to any scleroderma renal crisis), patients with acute myocardial infarction within six months or patients who are judged by the trial clinician to be at unacceptable risk from cardiac complications.
boolean
C0428772 (UMLS CUI [1])
C0332152 (UMLS CUI [2,1])
C1262147 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0030705 (UMLS CUI [4,1])
C1444641 (UMLS CUI [4,2])
C0161816 (UMLS CUI [4,3])
Substance Use Disorders chronic | Condition Associated with Poor compliance
Item
9. history of chronic alcohol or drug abuse or any condition associated with poor compliance as judged by the investigator
boolean
C0038586 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0032646 (UMLS CUI [2,3])
Cyclosporine A | Cyclosporine A Expected
Item
10. patients receiving cyclosporin a within 1 week of screening or expecting to receive this agent during the study.
boolean
C0010592 (UMLS CUI [1])
C0010592 (UMLS CUI [2,1])
C1517001 (UMLS CUI [2,2])
Investigational New Drugs
Item
11. patients who have received an investigational agent in the month prior to screening. these patients may be eligible if after a month of washout period, they are still within 112 months of the onset of the scleroderma renal crisis.
boolean
C0013230 (UMLS CUI [1])
Malignant Neoplasms | Neoplastic disease
Item
12. active malignancy or neoplastic disease in the previous 12 months
boolean
C0006826 (UMLS CUI [1])
C1882062 (UMLS CUI [2])
Gender | Estrogen Contraceptive Agents
Item
13. women who rely on oestrogencontaining contraceptives (due to potential drug interaction with zibotentan).
boolean
C0079399 (UMLS CUI [1])
C0009907 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
14. females who are pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial